0001062993-16-012691.txt : 20161213
0001062993-16-012691.hdr.sgml : 20161213
20161213103918
ACCESSION NUMBER: 0001062993-16-012691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161208
FILED AS OF DATE: 20161213
DATE AS OF CHANGE: 20161213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Thomas
CENTRAL INDEX KEY: 0001355189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 162047838
MAIL ADDRESS:
STREET 1: 1764 BRIAR PLACE
CITY: MERRICK
STATE: NY
ZIP: 11566
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2016-12-08
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001355189
Wegman Thomas
C/O BIOSPECIFICS TECHNOLOGIES CORP.,
35 WILBUR STREET
LYNBROOK
NY
11563
1
1
1
0
President
Common Stock, $.001 par value
2016-12-08
4
S
0
15000
49.5408
D
930879
D
The selling price of $49.5408 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.20 to $50.13. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman
2016-12-09